Mariannette Miller-Meeks

Mariannette Miller-Meeks has been the subject of several controversies and criticisms regarding her residency, conduct, and campaign finances, but there are no reported criminal indictments, charges, or convictions against her. In 2021, the House Sergeant at Arms fined Miller-Meeks for failing to wear a mask on the House floor. Regarding residency, critics have questioned her claims of living within her congressional district. A formal request for an ethics investigation into her residency claims was filed in September 2024 but was not acted upon. A challenge to her ballot in the 2024 general election regarding her residency status was rejected by local election officials. Miller-Meeks has faced scrutiny for renting a Washington, D.C., apartment from lobbyists who represented the pharmaceutical industry while she served on a House subcommittee overseeing drug pricing. While critics have raised concerns about potential conflicts of interest, Miller-Meeks’ office has maintained the agreement was a fair-market lease and stated there was no wrongdoing. Reports noted that this rental arrangement was not included in her annual House financial disclosure filings. Additionally, Miller-Meeks has been criticized for accepting campaign contributions from pharmaceutical and insurance political action committees while simultaneously opposing specific healthcare legislation, such as the extension of Affordable Care Act premium tax credits and certain drug pricing caps. Her office has stated that her positions often run counter to those of the pharmaceutical industry.